KHCC Performs First Laser-Guided Robotic Brain Tumor Surgery in Region

Amman -- The King Hussein Cancer Center (KHCC) has achieved a medical milestone, performing the Middle East’s first brain tumor surgery using a combination of laser thermal therapy, robotics, and magnetic resonance imaging (MRI) in a minimally invasive procedure.اضافة اعلان

The surgery was conducted on a 57-year-old patient with lung cancer that had metastasized to the right side of the brain. The patient was discharged in good health three days after the procedure.

This innovative surgery marks the first time such technology has been employed outside the United States and Western Europe. Dr. Asem Mansour, Director General of the King Hussein Cancer Center, hailed the procedure as a global medical achievement and a source of pride for Jordan. He emphasized the center’s dedication to staying at the forefront of cancer treatment and providing advanced care to patients in Jordan and the region.

Dr. Mansour commended the medical team’s expertise and expressed his satisfaction with the patient’s swift recovery, noting the significance of this accomplishment in advancing cancer care locally and regionally.

Dr. Mouness Obeidat, Head of the Brain and Nerve Tumor Surgery Department at the center, explained that the procedure integrates state-of-the-art robotic surgery with laser-guided technology and MRI support. This combination allows for unparalleled precision in treating complex brain tumors, particularly for patients for whom traditional surgeries are not viable due to the tumor’s type or location.

The minimally invasive procedure involves a small incision, which heals quickly, enabling patients to recover and leave the hospital within 24 hours. The process begins with a tiny opening in the skull, through which a robotic arm is inserted and guided toward the tumor.

The patient is then moved to an MRI machine within the operating room, ensuring precise navigation. A laser is activated to map and remove the tumor with exceptional accuracy.

According to Dr. Obeidat, the new technique is expected to benefit approximately 12 patients annually, aligning with treatment capacities at leading brain tumor surgery centers in Europe.

This achievement reinforces Jordan’s position as a regional leader in advanced medical technologies and innovative cancer treatments.